Summary
Emerging concepts in the aetiology and pathogenesis of Type 1 (insulin-dependent) diabetes mellitus may offer new opportunities for treatment and cure. Here we describe recent advances in structural molecular biology and molecular design relevant to rational drug discovery. Such approaches focus on the three-dimensional structures of macromolecules and their interactions. In the coming decade such techniques may be applied to a wide variety of diabetes-related targets.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bell GI (1991) Lilly Lecture: molecular defects in diabetes mellitus. Diabetes 40: 413–422
Bell GI, Xiang KS, Newman MV et al. (1991) Gene for non-insulin-dependent diabetes (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 88: 1484–1488
Froguel P, Vaxillaire M, Sun F et al. (1992) Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature 356: 162–164
Faustman D, Li X, Lin HY et al. (1991) Linkage of faulty major histocompalibility complex class 1 to autoimmune diabetes. Science 254: 1756–1761
Sun XJ, Rothenberg P, Kahn CR et al. (1991) Structure of the insulin receptor substrate (RS-) defines a unique signal transduction protein. Nature 352: 73–77
Skolnik EY, Margolis B, Mohammadi M et al. (1991) Cloning of PI 3 kinase-associated p 85 utilising a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65: 83–90
Blundell TL, Cutfield JF, Cutfield SM et al. (1971) Atomic position in 2-zinc insulin crystals. Nature 231: 506–511
Peking Insulin Structure Group (1971) Insulin's crystal structure at 2.5 Å resolution. Peking Rev 40: 11–16
Baker EN, Blundell TL, Cutfield GS et al. (1988) The structure of 2-Zn pig insulin crystals at 1.5: a resolution. Phil Trans R Soc B 319: 389–456
Mirmira R, Tager HS (1989) Role of the phenylalanine B24 sidechain in directing insulin interaction with its receptor: importance of mainchain conformation. J Biol Chem 264: 6349–6354
De Vos AM, Ultsch M, Kossiakoff AA (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255: 306–312
Ernst RR, Bodenhausen G, Wokaun A (1987) Principles of nuclear magnetic resonance in one and two dimensions. Clarendon Press, Oxford
Wagner G, Withrich K (1982) Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor. J Mol Biol 155: 347–366
Ikura M, Kay LE, Bax A (1990) A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance NMR spectroscopy. Application to calmodulin. Biochem 29: 4659–4667
Clore GM, Gronenborn AM (1983) Theory of the time dependent transferred nuclear overhauser effect: applications to structural analysis of ligand-protein complexes in solution. J Mag Reson 53: 423–442
Hua QX, Shoelson SE, Kochogan M, Weiss MA (1991) Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354: 238–241
Kline AD, Justice RM (1990) Complete sequence-specific 1H-NMR assignments for human insulin. Biochemistry 29: 2906–2913
Boelens R, Ganadu ML, Verheyden P, Kaptein R (1990) Two-dimensional NMR studies on des-pentapeptide-insulin: proton resonance assignments and secondary analysis. Eur J Biochem 191: 147–153
Weiss MA, Hua QX, Lynch CS, Frank BH, Shoelson SE (1991) Heteronuclear NMR studies of an engineered insulin monomer: characterisation of the receptor-binding surface by selective 2H and 13C isotopic labelling with application to protein design. Biochemistry 30: 7373–7389
Hua QX, Kochoyan M, Weiss MA (1992) Structure and dynamics of des-pentapeptide insulin in solution: the molten globule hypothesis. Proc Natl Acad Sci USA 89: 2379–2383
Rooman MJ, Wodak S (1988) Identification of predictive sequence motifs limited by protein structure data base size. Nature 335: 45–49
Rooman MJ, Kocher JP, Wodak SJ (1991) Prediction of protein backbone conformation based on seven structure assignments. J Mol Biol 221: 961–979
Sali A, Overington JP, Johnson MS, Blundell TL (1990) From comparisons of protein sequences and structures to protein modelling and design. Trends Biochem Sci 15: 235–240
Novotny J, Bruccoleri R, Karplus M (1984) An analysis of incorrectly folded protein models: implications for structure predictions. J Mol Biol 177: 787–818
Overington JP, Johnson MS, Sali A, Blundell TL (1990) Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction. Proc R Soc Lond Ser B 241: 132–145
Luthy R, McLachlan AD, Eisenberg DC (1991) Secondary structure-based profiles: use of structure-conserving scoring tables in searching protein sequence databases for structural similarities. Proteins 10: 229–239
Bowie JV, Luthy R, Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253: 164–170
Overington J, Donnelly D, Johnson MS, Sali A, Blundell TL (1992) Environment-specific amino acid substitution tables: tertiary templates and prediction of protein folds. Protein Sci 1: 216–226
Knighton DR, Zheng J, Ten Eyck LF et al. (1991) Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253: 407–413
Mayer D, Naylor CB, Motoc I, Marshall GR (1987) A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies. J Comput Aided Mol Des 1: 3–16
Amit AG, Mariuzza RA, Phillips SE, Poljak RJ (1986) Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233: 747–753
Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR (1989) Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA 86: 5938–5942
Bhat TN, Bentley GA, Fischmann TO, Boulot G, Poljak RJ (1990) Small rearrangements in structure of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature 347: 483–485
Roberts VA, Iverson BL, Iverson SA et al. (1990) Anti body remolding: a general solution to the design of a metal-coordination site in an antibody binding site. Proc Natl Acad Sci USA 87: 6654–6658
Bentley GA, Boulot G, Riottot MM, Poljak RJ (1990) Three dimensional structure of an idiotope-anti-idiotope complex. Nature 348: 254–257
Veerapandian B, Cooper JB, Sali A et al. (1992) Direct observation by X-ray analysis of the tetrahedral “intermediate” of aspartic proteinases. Protein Sci 1: 322–328
Getzoff ED, Cabelli DE, Fisher CL et al. (1992) Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358: 347–351
Cushman DW, Cheung HS, Sabo EF, Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme, carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochem 16: 5484–5491
Ulm EH, Greenlee WJ (1989) Inhibitors of the renin-angiotensin system enzymes. In: Sandler M, Smith HJ (eds) Design of enzyme inhibitors as drugs. Oxford University Press, New York, pp 146–177
Martin JL, Johnson LN, Withers SG (1990) Comparison of the binding of glucose and glucose l-phosphate derivatives to T-state glycogen phosphorylase b. Biochem 29: 10745–10757
Martin JL, Veluraja K, Ross K et al. (1991) Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochem 30: 10101–10116
Goodford PJ (1985) A computational procedure for determining energetically favourable binding sites on biologically important molecules. J Med Chem 28: 849–857
Folkers G, Krickl S, Trumpp S (1989) Localisation of the essential structure for binding of antiviral agents to thymidine kinase by studying sequence homologies. Arch Pharm 322: 409–413
Folkers G, Sakahara K, Schwabel W, Eger K (1989) The development of pharmacophore models for thymidine-kinase-dependent virostatic nucleoside analogues. Arch Pharm 322: 395–398
Folkers G, Trumpp-Kallmeyer S, Gutbrod O, Krickl S, Fetzer J, Keil GM (1991) Computer-aided active-site directed modeling of the herpes simplex virus 1 and human thymidine kinase. J Comput Aided Mol Des 5: 385–404
Zimmermann N, Beck-Sickinger AG, Folkers G, Krickl S, Muller I, Jung G (1991) Conformational and epitope mapping of herpes-simplex-virus-type 1 thymidine kinase using synthetic peptide segments. Eur J Biochem 200: 519–528
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blundell, T., Hubbard, R. & Weiss, M.A. Structural biology and diabetes mellitus: molecular pathogenesis and rational drug design. Diabetologia 35 (Suppl 2), S69–S76 (1992). https://doi.org/10.1007/BF00586281
Issue Date:
DOI: https://doi.org/10.1007/BF00586281